Treatment of patients with unstable angina and non-ST elevation myocardial infarction

Jeffrey Tabas1, Erin McNutt

  • 1University of California San Francisco School of Medicine, USA. jtabas@sfghed.ucsf.edu

Insights

Emergency department clinicians face challenges managing suspected unstable angina (UA) and non-ST elevation myocardial infarction (NSTEMI). This review clarifies treatment selection based on ACC/AHA recommendations for suspected UA and STEMI.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Practice Guidelines

Background:

  • Management of suspected unstable angina (UA) and non-ST elevation myocardial infarction (NSTEMI) in the emergency department (ED) presents unique challenges.
  • Therapeutic benefits proven for confirmed disease may not apply to suspected cases, requiring careful risk-benefit assessment.

Purpose of the Study:

  • To review current literature on the management of suspected UA and NSTEMI.
  • To discuss American College of Cardiology (ACC) and American Heart Association (AHA) treatment recommendations for UA and ST-elevation myocardial infarction (STEMI).

Main Methods:

  • Literature review of current scientific articles.
  • Analysis of ACC and AHA clinical practice guidelines.

Main Results:

  • Therapies effective for proven myocardial infarction may not be indicated for suspected cases.
  • Emergency practitioners need a clear understanding of therapy benefits and harms for appropriate treatment selection.

Conclusions:

  • A simplified approach to treatment selection is needed for emergency practitioners managing suspected UA and NSTEMI.
  • Adherence to ACC/AHA guidelines is crucial for optimizing patient care in acute coronary syndromes.

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...